U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396909) titled 'A First-in-Human Single and Multiple Ascending Dose Study of MT-701' on Feb. 02.
Brief Summary: First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-701 in healthy participants.
Study Start Date: Jan. 12
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: MT-701
MT-701
Recruitment Status: RECRUITING
Sponsor: Mirador Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....